On November 10, 2020 Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, reported that it will host a conference call for the investment community to pose questions related to the Company’s third quarter 2020 financial and operating results (Press release, Novavax, NOV 10, 2020, https://ir.novavax.com/news-releases/news-release-details/novavax-host-conference-call-questions-related-third-quarter [SID1234570516]). The call will be held because of technical issues experienced by the Company’s external conference call host during the earnings call that took place on November 9 at 4:30 pm. The call will be held following the close of U.S. financial markets on Tuesday, November 10, 2020.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference call details are as follows:

Date: November 10, 2020
Time: 4:30 p.m. U.S. Eastern Time (ET)
Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Conference ID: 1376583
Webcast: www.novavax.com, "For Investors"/ "Events"

Conference call webcast replay:

Dates: Starting at 7:30 p.m. ET, November 10, 2020 until 7:30 p.m. ET November 17, 2020
Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International)
Conference ID: 1376583
Webcast: www.novavax.com, "For Investors"/ "Events" until 11/17/2020